LON:GLB Glanbia (GLB) Share Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free GLB Stock Alerts GBX 17.76 +0.26 (+1.47%) (As of 05:19 PM ET) Add Compare Share Share Today's Range 17.69▼ 18.1050-Day Range 15.19▼ 18.1052-Week Range 13.08▼ 18.52Volume160,133 shsAverage Volume77,544 shsMarket Capitalization£46.48 millionP/E Ratio14.92Dividend Yield197.11%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendHeadlinesStock AnalysisChartCompetitorsDividendHeadlines Get Glanbia alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Glanbia Stock (LON:GLB)Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; property leasing; business services; management solutions; weight management; flavor solutions; and bioactive solutions businesses. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, SlimFast, think!, Amazing Grass, Body & Fit, and LevlUp brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.Read More GLB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GLB Stock News HeadlinesApril 17, 2024 | finance.yahoo.comWeight Management Supplement Market Set to Soar at 14.2% CAGR through 2034 Amid Rising Prevalence of Obesity Globally | Future Market Insights, Inc.April 16, 2024 | wsj.comGlanbia PLCApril 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.April 4, 2024 | finance.yahoo.comGlobal Chia Seeds Market Size To Worth USD 1960 Million By 2033 | CAGR of 7.10%March 27, 2024 | finance.yahoo.comGlobal Immune Health Supplements Outlook & Forecasts Report 2024-2029: Rising Preference for Gummies, Soft Gel, and Effervescent TabletsMarch 18, 2024 | finanznachrichten.deThe Hain Celestial Group: Hain Celestial Group Appoints Seasoned Executive Chad Marquardt as President of North AmericaMarch 18, 2024 | finance.yahoo.comHain Celestial Group Appoints Seasoned Executive Chad Marquardt as President of North AmericaMarch 6, 2024 | finance.yahoo.comMicellar Casein Market to exceed $8.3 Bn by 2032, Says Global Market Insights Inc.April 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.February 28, 2024 | msn.comGlanbia sees profits jump 20.2pc in 2023February 28, 2024 | msn.comStrong demand boosts Glanbia despite a fall in revenueFebruary 11, 2024 | benzinga.comLatest News for Coinbase Glb Stock (NASDAQ:COIN)February 6, 2024 | finance.yahoo.comSports Nutrition Market In Europe to grow by USD 3.67 billion from 2022 to 2027; Rising inclination toward fitness boosts the market growth-TechnavioFebruary 2, 2024 | msn.comMarkets rethink US rate cuts after bumper day for tech profits and jobsJanuary 2, 2024 | finance.yahoo.comClinical nutrition market Size Worth USD 78.77 Billion in 2032 | Emergen ResearchDecember 12, 2023 | finance.yahoo.comFunctional Foods and Beverages Market to Hit USD 529.66 Billion by 2028 | Exclusive Report by Fortune Business Insights™December 11, 2023 | finance.yahoo.comCheese Market to grow by USD 39.08 billion from 2023-2027 | The increasing growth of online retailing is a key trendDecember 11, 2023 | uk.finance.yahoo.comSports Nutrition Market to Rally to USD 80.71 Billion by 2028, Driven by Increased Global Fitness AwarenessDecember 4, 2023 | benzinga.comMilk Protein Concentrate Market to Cross US$ 7.64 Billion at 6.7% CAGR by 2034: Fact.MR AnalysisDecember 1, 2023 | benzinga.comCheese Market to grow by USD 39.08 billion from 2023-2027 | The rising adoption of cheese products in different cuisines to drive the market growthNovember 22, 2023 | msn.comOptimum Nutrition expands investments in Middle East, Turkey, AfricaNovember 19, 2023 | benzinga.comLiquid Dietary Supplement Market Size Worth US$ 120 Billion by 2034: Fact.MR ReportNovember 12, 2023 | lse.co.ukWisdomtree Glb Qual Div Grow Ucits Etf H Share Price (GGRE.MI)November 6, 2023 | finance.yahoo.comProtein Powder Market to Attain a Value of $38.29Bn Globally by 2030 - Exclusive Report by The Insight PartnersNovember 1, 2023 | benzinga.comProtein Supplements Market Set for Remarkable Growth, Aiming for USD 46.12 Billion by 2030 with 8.34% CAGR, States Straits ResearchNovember 1, 2023 | msn.comFood group Glanbia upgrades full year earnings guidanceOctober 27, 2023 | finance.yahoo.comOats Market Size to Worth USD 6.90 Billion by 2027 | Comprehensive 122 Pages Research ReportSee More Headlines Receive GLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Glanbia and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 5/3 Dividend3/21/2024Today4/24/2024Dividend Payable5/03/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorConsumer Defensive Industry Packaged Foods Sub-IndustryN/A Current SymbolLON:GLB CUSIPN/A CIKN/A Webwww.glanbia.com Phone+353-56-7772200FaxN/AEmployees5,534Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 1.19 Trailing P/E Ratio14.87 Forward P/E Ratio13.64 P/E Growth8.32Net Income£347.60 million Net Margins6.35% Pretax MarginN/A Return on Equity16.86% Return on Assets5.45% Debt Debt-to-Equity Ratio36.19 Current Ratio1.68 Quick Ratio0.86 Sales & Book Value Annual Sales£5.43 billion Price / Sales0.01 Cash FlowGBX 128.94 per share Price / Cash Flow0.14 Book ValueGBX 812 per share Price / Book0.02Miscellaneous Outstanding Shares261,760,000Free FloatN/AMarket Cap£46.31 million OptionableNot Optionable Beta0.53 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Mark A. Garvey (Age 60)CFO & Executive Director Comp: $2.03MMr. Hugh McGuire Dip Finance (Age 53)M.Sc, CEO & Executive Director Mr. Liam HenniganGroup Secretary & Head of Investor RelationsMs. Martha KavanaghHead of Corporate CommunicationsMr. Ian Doyle (Age 46)Chief Corporate Development Officer Ms. Sue Sweem (Age 60)Chief Human Resources Officer Mr. Michael Patten (Age 62)Chief ESG & Corporate Affairs Officer Mr. Tom Tench (Age 53)Chief Operating Officer of Glanbia Nutritionals Mr. Brian Phelan B. Comm (Age 57)FCA, Chief Executive Officer of Glanbia Nutritionals Mr. Jim Bergin (Age 61)Chief Executive of Glanbia Ingredients Ireland Limited More ExecutivesKey CompetitorsAnparioLON:ANPScience in SportLON:SISOcean Harvest Technology GroupLON:OHTZambeef ProductsLON:ZAMCarr's GroupLON:CARRView All Competitors GLB Stock Analysis - Frequently Asked Questions How have GLB shares performed in 2024? Glanbia's stock was trading at GBX 14.30 at the beginning of 2024. Since then, GLB shares have increased by 24.3% and is now trading at GBX 17.78. View the best growth stocks for 2024 here. How often does Glanbia pay dividends? What is the dividend yield for Glanbia? Glanbia announced a dividend on Wednesday, February 28th. Shareholders of record on Thursday, March 21st will be given a dividend of GBX 0.21 per share on Friday, May 3rd. This represents a dividend yield of 1.38%. The ex-dividend date of this dividend is Thursday, March 21st. This is a boost from the stock's previous dividend of GBX 0.14. The official announcement can be accessed at this link. Read our dividend analysis for GLB. Is Glanbia a good dividend stock? Glanbia (LON:GLB) pays an annual dividend of GBX 35 per share and currently has a dividend yield of 1.98%. The dividend payout ratio is 2,941.18%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for GLB. What other stocks do shareholders of Glanbia own? Based on aggregate information from My MarketBeat watchlists, some companies that other Glanbia investors own include Reckitt Benckiser Group (RB), Kerry Group (KRYAY), Kimberly-Clark (KMB), Glanbia (GLAPY), Glanbia (GLAPF), Diageo (DEO), Dalata Hotel Group (DAL), Bank of Ireland Group (BIRG), Atalaya Mining (ATYM) and Amryt Pharma (AMYT). How do I buy shares of Glanbia? Shares of GLB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:GLB) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss RatingsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Glanbia plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
